ToolGen gets FDA approval for TGT-001 as ODD

South Korean genome editing developer ToolGen Inc. announced on Monday that its application for orphan drug designation (ODD) of the gene correction...
South Korean genome editing developer ToolGen Inc. announced on Monday that its application for orphan drug designation (ODD) of the gene correction...
AIOBIO’s dental diagnostic devices will be covered by South Korea’s national health insurance from June 1. AIOBIO is the country’s...
Life is so unpredictable. I feel this looking at myself who has been living in Korea for 3 years now marrying a Korean guy from Gyeongju and traveling...